Abstract Background Coronavirus (COVID‐19) infection exposes patients with heart failure
specially who are on mechanical support to a higher risk of morbidity and mortality. Aims To …

We present the first reported case of left ventricular assist device (LVAD) pump thrombosis in
the setting of the coronavirus pandemic. We describe the clinical features of the case which …

Background The outbreak of coronavirus disease 2019 (COVID-19) exposes vulnerable
patients to high risk of mortality. Patients with left ventricular assist device (LVAD) usually …

Patients on left ventricular assist device (LVAD) support may be susceptible to severe
disease and complications from coronavirus disease-19 (COVID-19). The purpose of this …

Left ventricular assist device (LVAD) implantation is an established treatment for patients
with end-stage, systolic heart failure as a bridge to heart transplantation or destination …

The coronavirus disease-2019 (COVID-19) pandemic has afflicted more than 4 million
people in the United States and carries a high mortality rate. Preexisting cardiovascular …

Abstract The coronavirus 2019 disease (COVID‐19) affected 125 million people worldwide
and caused 2.7 million deaths. Some comorbidities are associated with worse prognosis …

The novel coronavirus disease 2019 (COVID-19) is an infectious disease with multi-organ
involvement, including the cardiovascular system. The disease may cause several …

Patient's respiratory status worsened over the next day necessitating endotracheal
intubation. LVAD flows declined to 2.0 to 2.5 L/min without changes in pulsatility index or …

Background: The coronavirus disease 2019 (COVID-19) pandemic continues to afflict
millions of people worldwide. Patients with end-stage heart failure and left ventricular assist …